
While Boehringer Ingelheim develops a range of chemical products, including animal health treatments and biopharmaceuticals, human pharmaceuticals account for 95 percent of the company’s sales.
SHANGHAI German pharmaceutical company Boehringer Ingelheim has called a creative review of its US$5 million Mucosolvan cough medicine brand in China, with four agencies, including incumbent Publicis and Y&R, believed to be competing for the account.
Top news, insights and analysis every weekday
Sign up for Campaign Bulletins
Publicis Media came in swinging in 2024—snagging big-name clients, racking up awards and riding a wave of regional growth. But with rivals regrouping and the AI race tightening, the fight for APAC dominance is far from over.
Laopu Gold posted impressive sales figures during the 618 shopping festival, setting the potential for further growth and brand expansion by tapping Chinese cultural identity.
As part of its expanding ad portfolio, Uber has introduced Ride Offers, a feature that rewards riders with ride discounts when they engage with targeted adverts in the app.
In a wide-ranging interview, John explains how APAC work, like New Zealand’s stigma-smashing Grand Prix for Good and Ogilvy Singapore’s work for Vaseline, are setting the stage for global creative change.